Would You Still Hold Insulet Stock If It Fell Another 30%?
Insulet (PODD) stock is down 14.4% in 21 trading days. The recent slide reflects renewed concerns around broader market weakness and potential GLP-1 drug impacts on Omnipod sales, but sharp drops like this often raise a tougher question: is the weakness temporary, or a sign of deeper cracks in the story?
Before judging its downturn reslience, let’s look at where Insulet stands today.
- Size: Insulet is a $20 Bil company with $2.5 Bil in revenue currently trading at $288.82.
- Fundamentals: Last 12 month revenue growth of 27.1% and operating margin of 17.3%.
- Liquidity: Has Debt to Equity ratio of 0.05 and Cash to Assets ratio of 0.25
- Valuation: Insulet stock is currently trading at P/E multiple of 82.5 and P/EBIT multiple of 55.9
- Has returned (median) -23.1% within a year following sharp dips since 2010. See PODD Dip Buy Analysis.
These metrics point to a Strong operational performance, alongside Very High valuation – making the stock Relatively Expensive. For details, see Buy or Sell PODD Stock
That brings us to the key consideration for investors worried about this fall: how resilient is PODD stock if markets turn south? This is where our downturn resilience framework comes in. Suppose PODD stock falls another 20-30% to $202 – can investors comfortably hold on? Turns out, the stock has fared worse than the S&P 500 index during various economic downturns, based on (a) how much the stock fell and, (b) how quickly it recovered. Below, we dive deeper into each such downturn.
2022 Inflation Shock
- PODD stock fell 61.3% from a high of $330.23 on 12 May 2023 to $127.77 on 12 October 2023 vs. a peak-to-trough decline of 25.4% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 20 August 2025
- Since then, the stock increased to a high of $352.82 on 9 September 2025 , and currently trades at $288.82
| PODD | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -61.3% | -25.4% |
| Time to Full Recovery | 678 days | 464 days |
2020 Covid Pandemic
- PODD stock fell 39.9% from a high of $216.44 on 20 February 2020 to $130.01 on 18 March 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 8 May 2020
| PODD | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -39.9% | -33.9% |
| Time to Full Recovery | 51 days | 148 days |
2018 Correction
- PODD stock fell 33.0% from a high of $108.13 on 13 September 2018 to $72.44 on 3 January 2019 vs. a peak-to-trough decline of 19.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 24 May 2019
| PODD | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -33.0% | -19.8% |
| Time to Full Recovery | 141 days | 120 days |
2008 Global Financial Crisis
- PODD stock fell 90.3% from a high of $27.46 on 30 November 2007 to $2.67 on 11 March 2009 vs. a peak-to-trough decline of 56.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 7 May 2013
| PODD | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -90.3% | -56.8% |
| Time to Full Recovery | 1,518 days | 1,480 days |
Feeling jittery about PODD stock? Consider portfolio approach.
Move Beyond Single Stocks With A Multi Asset Portfolio
Individual picks are volatile but diversified assets offset each other. A multi asset portfolio helps you stay the course capture upside and reduce downside.
The asset allocation framework of Trefis’ Boston-based, wealth management partner yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Our partner’ strategy now includes Trefis High Quality Portfolio, which has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices